These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 26046489)
1. Effective Biomarkers and Radiation Treatment in Head and Neck Cancer. Ow TJ; Pitts CE; Kabarriti R; Garg MK Arch Pathol Lab Med; 2015 Nov; 139(11):1379-88. PubMed ID: 26046489 [TBL] [Abstract][Full Text] [Related]
2. [Biallelic inactivation of the p16-Gen in a metachronous triple carcinoma in the oropharyngeal region]. Motsch C; Giers A; Boltze C; Evert M; Freigang B; Roessner A; Schneider-Stock R Laryngorhinootologie; 2004 Jan; 83(1):55-60. PubMed ID: 14740307 [TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling to predict outcome after chemoradiation in head and neck cancer. Pramana J; Van den Brekel MW; van Velthuysen ML; Wessels LF; Nuyten DS; Hofland I; Atsma D; Pimentel N; Hoebers FJ; Rasch CR; Begg AC Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1544-52. PubMed ID: 17931799 [TBL] [Abstract][Full Text] [Related]
4. A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck. Hanna E; Shrieve DC; Ratanatharathorn V; Xia X; Breau R; Suen J; Li S Cancer Res; 2001 Mar; 61(6):2376-80. PubMed ID: 11289099 [TBL] [Abstract][Full Text] [Related]
5. MicroRNAs Involvement in Radioresistance of Head and Neck Cancer. Ahmad P; Sana J; Slavik M; Slampa P; Smilek P; Slaby O Dis Markers; 2017; 2017():8245345. PubMed ID: 28325958 [TBL] [Abstract][Full Text] [Related]
6. A novel panel of biomarkers predicts radioresistance in patients with squamous cell carcinoma of the head and neck. Akervall J; Nandalur S; Zhang J; Qian CN; Goldstein N; Gyllerup P; Gardinger Y; Alm J; Lorenc K; Nilsson K; Resau J; Wilson G; Teh B Eur J Cancer; 2014 Feb; 50(3):570-81. PubMed ID: 24332450 [TBL] [Abstract][Full Text] [Related]
7. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615 [TBL] [Abstract][Full Text] [Related]
9. Emerging Concepts in Head and Neck Squamous Cell Carcinoma. Prystowsky MB Arch Pathol Lab Med; 2015 Nov; 139(11):1332-3. PubMed ID: 26516936 [No Abstract] [Full Text] [Related]
10. Molecular genetics of head and neck cancer (Review). Arora S; Aggarwal P; Pathak A; Bhandari R; Duffoo F; Gulati SC Mol Med Rep; 2012 Jul; 6(1):19-22. PubMed ID: 22552728 [TBL] [Abstract][Full Text] [Related]
11. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA. Lu DW; El-Mofty SK; Wang HL Mod Pathol; 2003 Jul; 16(7):692-9. PubMed ID: 12861066 [TBL] [Abstract][Full Text] [Related]
12. p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma. Jayasurya R; Francis G; Kannan S; Lekshminarayanan K; Nalinakumari KR; Abraham T; Abraham EK; Nair MK Int J Cancer; 2004 May; 109(5):710-6. PubMed ID: 14999779 [TBL] [Abstract][Full Text] [Related]
13. Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients. Farnebo L; Tiefenböck K; Ansell A; Thunell LK; Garvin S; Roberg K Int J Cancer; 2013 Oct; 133(8):1994-2003. PubMed ID: 23564498 [TBL] [Abstract][Full Text] [Related]
14. Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma. Rosenthal DI; Ang KK Semin Radiat Oncol; 2004 Apr; 14(2):153-66. PubMed ID: 15095261 [TBL] [Abstract][Full Text] [Related]
15. TP53 mutations in head and neck cancer. Perrone F; Bossi P; Licitra L N Engl J Med; 2008 Mar; 358(11):1194-5; author reply 1195. PubMed ID: 18340660 [No Abstract] [Full Text] [Related]
16. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience. Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834 [TBL] [Abstract][Full Text] [Related]
17. Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance. Kim SH; Lee SY; Park HR; Sung JM; Park AR; Kang S; Kim BG; Choi YP; Kim YB; Cho NH Cancer; 2011 May; 117(9):1864-73. PubMed ID: 21509763 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of the p53 gene in primary and metastatic head and neck carcinomas. Sauter ER; Ridge JA; Trock B; Cleveland D; Whitley KV; Mohr RM; Klein-Szanto A Laryngoscope; 1995 Jun; 105(6):653-6. PubMed ID: 7769953 [TBL] [Abstract][Full Text] [Related]
19. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers. Ji X; Neumann AS; Sturgis EM; Adler-Storthz K; Dahlstrom KR; Schiller JT; Wei Q; Li G Carcinogenesis; 2008 Apr; 29(4):875-9. PubMed ID: 18258602 [TBL] [Abstract][Full Text] [Related]
20. Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck. Farhadieh RD; Smee R; Rees CG; Salardini A; Eggleton S; Yang JL; Russell PJ ANZ J Surg; 2009; 79(1-2):48-54. PubMed ID: 19183379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]